Pluri Inc. Cash and Restricted Cash
Pluri Inc. (PLUR) had Cash and Restricted Cash of $4.58 million as of 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-09-10
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.58M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.59M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.85M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.60M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $4.58M 10-K · filed 2026-09-10 | |
| 2026-03-31 | $4.59M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $5.85M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $5.60M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $7.20M 10-K · filed 2026-09-10 | |
| 2025-03-31 | $9.69M 10-Q · filed 2026-05-14 | |
| 2024-12-31 | $8.29M 10-Q · filed 2026-02-12 | |
| 2024-09-30 | $4.22M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $7.67M 10-K · filed 2026-09-10 | |
| 2024-03-31 | $7.99M 10-Q · filed 2025-05-13 | |
| 2023-12-31 | $6.49M 10-Q · filed 2025-02-11 | |
| 2023-09-30 | $6.16M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $6.26M 10-K · filed 2025-09-17 | |
| 2023-03-31 | $4.58M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $10.17M 10-Q · filed 2024-02-12 | |
| 2022-09-30 | $10.03M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $11.41M 10-K · filed 2024-09-18 | |
| 2022-03-31 | $24.93M 10-Q · filed 2023-05-09 | |
| 2021-12-31 | $19.22M 10-Q · filed 2023-02-13 | |
| 2021-09-30 | $15.22M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $31.84M 10-K · filed 2023-09-12 | |
| 2021-03-31 | $12.85M 10-Q · filed 2022-05-09 | |
| 2020-12-31 | $8.30M 10-Q · filed 2022-02-07 | |
| 2020-09-30 | $7.59M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $9.23M 10-K · filed 2022-09-21 | |
| 2020-03-31 | $7.83M 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $8.27M 10-Q · filed 2021-02-08 | |
| 2019-09-30 | $4.67M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $5.19M 10-K · filed 2021-09-13 | |
| 2019-03-31 | $10.24M 10-Q · filed 2020-05-11 | |
| 2018-12-31 | $7.71M 10-Q · filed 2020-02-06 | |
| 2018-09-30 | $9.21M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $9.89M 10-K · filed 2020-09-10 | $9.51M 10-Q · filed 2018-11-07 |
| 2018-03-31 | $6.63M 10-Q · filed 2019-05-06 | |
| 2017-12-31 | $9.15M 10-Q · filed 2019-02-06 | |
| 2017-09-30 | $12.89M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $5.67M 10-K · filed 2020-09-10 | $5.27M 10-Q · filed 2018-11-07 |
| 2016-06-30 | $7.12M 10-K · filed 2019-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |